HG&H Pharmaceuticals (Pty) Ltd are the propriety owners of Zembrin.
Zembrin is the only patented, standardized Sceletium spp. and is considered a cutting-edge ingredient for brain health products that aid in cognition, improvement of mood and reducing stress.
Zembrin has a global presence, distributed by 7 companies in 8 countries.
Up to 72 products containing Zembrin have been formulated so far.